The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes

Inclusion Criteria: * Informed oral and written consent * Diagnosed with type 2 diabetes according to the criteria of the WHO * HbA1C: 7-11% (doing treatment with diet and/or metformin) * Age \>18 years * BMI \>25 kg/m2 \<40 kg/m2 * Negative islet cell antibodies (ICA) and glutamate decarboxylase 65 (GAD- 65) autoantibodies Exclusion Criteria: * Females of child bearing potential who are pregnant, breast-feeding or have intention of becoming pregnant or are not using adequate contraceptive measures. * Subjects treated with sulfonylureas, dipeptidyl peptidase 4 (DPP-4) inhibitors, insulin or glitazones * Ongoing abuse of alcohol or narcotics * Impaired hepatic function (liver transaminases \>2 times upper normal limit) * Impaired renal function (se-creatinine \>150μM and/or albuminuria) * Cardiac problems defined as decompensated heart failure (NYHA class III or IV), unstable angina pectoris and/or myocardial infarction within the last 12 months * Uncontrolled hypertension (systolic blood pressure \>180 mmHg, diastolic blood pressure \>100 mmHg) * Anaemia * Any condition that the investigators feels would interfere with trial participation * Receiving any investigational drug within the last 3 months